RT Book, Section
A1 Dolan, Brigid
A1 Walsh, Judith
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1184155397
T1 Sexuality & Sexual Health in Women
T2 Current Medical Diagnosis & Treatment 2022
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264269389
LK accessmedicine.mhmedical.com/content.aspx?aid=1184155397
RD 2024/04/19
AB Approximately  40–50%  of  women  will  experience  concerns  pertaining  to  sexual  health  during  their  lifetime.  DSM-5  updated  the  classification  of  female  sexual  dysfunction,  combining  hypoactive  sexual  desire  disorder  (HSDD)  and  sexual  arousal  disorder  into  a  larger  category  termed  “female  sexual  interest  or  arousal  disorder.”  Despite  this  reclassification,  some  groups  recommend  maintaining  the  two  as  separate  clinical  entities  due  to  disparate  pathophysiology  and  specific  evidence  supporting  treatments  for  HSDD.  Additional  conditions  that  may  impact  female  sexual  health  include  female  orgasmic  disorder  and  genitopelvic  pain  or  penetration  disorder.  When  diagnosing  any  sexual  health  disorder,  symptoms  must  be  present  for  6  months,  be  personally  distressing  to  the  patient,  and  meet  at  least  three  of  six  specific  criteria  related  to  symptoms  and  frequency  (outlined  in  DSM-5)  to  ensure  an  accurate  diagnosis.  Duration  criteria  may  limit  overdiagnosis  as  transient  factors  commonly  impact  sexual  function,  such  as  relationship  conflict  or  other  life  events.